GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)
Price and Volume
Detailed Quote| Volume | 497,483 |
| Open | 3.590 |
| Bid (Size) | 3.510 (6,000) |
| Ask (Size) | 3.520 (1,300) |
| Prev. Close | 3.650 |
| Today's Range | 3.450 - 3.640 |
| 52wk Range | 1.770 - 3.890 |
| Shares Outstanding | 412,429 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
9.6% below 52-week high
3.515
1.7752W Low
3.8952W High
1 Week
7.5% below 1-week high
3.331W Low
3.801W High
GoodRx Holdings, Inc. - Class A Common Stock (GDRX) traded between $1.77 and $3.89 over the past 52 weeks and last traded at $3.52, 9.6% below its 52-week high. Over the past week it ranged between $3.33 and $3.80.
Past 12 Months
+0.7%
+1.0%
-4.0%
+23.8%
+27.8%
+14.9%
1W
+$0.02
1M
+$0.04
3M
-$0.15
6M
+$0.68
YTD
+$0.77
1Y
+$0.46
GDRX was +14.9% over the past year, +23.8% over six months, +27.8% year to date, +0.7% in the last week.
12 Months vs Market
GDRX
+14.9%
DIA
+9.7%
SPY
+9.5%
QQQ
+7.5%
IWM
+14.1%
Over the past 12 months GDRX returned +14.9% versus DIA (Dow) +9.7%, SPY (S&P 500) +9.5%, QQQ (Nasdaq 100) +7.5% and IWM (Russell 2000) +14.1%.
Volume & Liquidity
0.41× 3-mo avg
Today 497,483
3-mo avg 1.2M
1W
1.3M
1M
1.2M
3M
1.2M
6M
1.3M
YTD
1.8M
1Y
1.9M
GDRX most recently traded 497,483 shares against a 3-month average daily volume of 1.2M.
More News
Read More
3 Cash-Producing Stocks We Steer Clear Of
October 06, 2026
Via StockStory
3 Reasons to Avoid GDRX and 1 Stock to Buy Instead
October 05, 2026
Via StockStory
Topics
Supply Chain
1 Value Stock to Target This Week and 2 That Underwhelm
September 29, 2026
Via StockStory
3 of Wall Street’s Favorite Stocks We Approach with Caution
September 14, 2026
Via StockStory
1 Momentum Stock with Exciting Potential and 2 That Underwhelm
September 01, 2026
Via StockStory
GoodRx (GDRX) Q2 2026 Earnings Call Transcript ↗
August 12, 2026
Via The Motley Fool
Topics
Earnings
1 Small-Cap Stock with Solid Fundamentals and 2 Facing Headwinds
August 11, 2026
Via StockStory
Via StockStory
Topics
Artificial Intelligence
1 Stock Under $10 with Exciting Potential and 2 Facing Headwinds
August 07, 2026
Via StockStory
GoodRx Q2 Earnings Call Highlights ↗
August 06, 2026
Via MarketBeat
Topics
Earnings
GoodRx (NASDAQ:GDRX) Reports Upbeat Q2 CY2026, Stock Soars
August 05, 2026
Via StockStory
GoodRx Reports Second Quarter 2026 Results
August 05, 2026
Via Business Wire
GoodRx Earnings: What To Look For From GDRX
August 03, 2026
Via StockStory
Via StockStory
GoodRx (GDRX): Buy, Sell, or Hold Post Q1 Earnings?
July 21, 2026
Via StockStory
Via StockStory
GoodRx (GDRX) Stock Trades Up, Here Is Why
July 13, 2026
Via StockStory
Frequently Asked Questions
Is GoodRx Holdings, Inc. - Class A Common Stock publicly traded?
Yes, GoodRx Holdings, Inc. - Class A Common Stock is publicly traded.
What exchange does GoodRx Holdings, Inc. - Class A Common Stock trade on?
GoodRx Holdings, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GoodRx Holdings, Inc. - Class A Common Stock?
The ticker symbol for GoodRx Holdings, Inc. - Class A Common Stock is GDRX on the Nasdaq Stock Market
What is the current price of GoodRx Holdings, Inc. - Class A Common Stock?
The current price of GoodRx Holdings, Inc. - Class A Common Stock is 3.515
When was GoodRx Holdings, Inc. - Class A Common Stock last traded?
The last trade of GoodRx Holdings, Inc. - Class A Common Stock was at 11/10/26 12:02 PM ET
What is the market capitalization of GoodRx Holdings, Inc. - Class A Common Stock?
The market capitalization of GoodRx Holdings, Inc. - Class A Common Stock is 1.45M
How many shares of GoodRx Holdings, Inc. - Class A Common Stock are outstanding?
GoodRx Holdings, Inc. - Class A Common Stock has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>